Health Care & Life Sciences » Pharmaceuticals | Daewon Pharmaceutical Co. Ltd.

Daewon Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
12,233
15,597
17,333
19,723
10,275
23,286
Depreciation, Depletion & Amortization
4,042
4,326
5,979
7,469
8,699
10,399
Other Funds
-
5
-
-
7
10,027
Funds from Operations
19,681
27,005
27,707
34,537
25,842
43,713
Changes in Working Capital
6,685
8,916
1,439
13,504
21,498
3,856
Net Operating Cash Flow
12,996
18,089
26,267
21,033
4,344
39,857
Capital Expenditures
9,927
15,867
23,283
20,573
17,721
Sale of Fixed Assets & Businesses
16
23
15
65
107
Purchase/Sale of Investments
6,998
639
157
621
1,680
Net Investing Cash Flow
17,578
14,674
23,178
20,406
20,088
Cash Dividends Paid - Total
702
1,158
2,431
3,403
4,521
Issuance/Reduction of Debt, Net
-
-
3,000
-
10,000
Net Financing Cash Flow
404
1,173
5,245
5,766
5,430
Net Change in Cash
4,986
2,243
2,155
5,139
10,302
Free Cash Flow
3,147
2,252
6,464
3,692
10,367
Other Sources
1,941
1,177
971
2,906
1,052
Change in Capital Stock
298
10
187
2,363
43
Exchange Rate Effect
-
-
-
-
13
Other Uses
2,610
646
1,038
3,426
1,846

About Daewon Pharmaceutical Co.

View Profile
Address
386 Cheonho-daero
Seoul SL 04808
Korea, Republic Of
Employees -
Website http://www.daewonpharm.com
Updated 07/08/2019
Daewon Pharmaceutical Co., Ltd. engages in the production and sale of pharmaceutical products. It offers multivitamins, antipyretics, analgesics and antiinflammatory, gastrointestinal, endocrine, antimicrobial, psychoneurotic, respiratory, cardiovascular and neuromuscular drugs. The company was founded by Baek Boo-Hyeon on August 9, 1961 and is headquartered in Seoul, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.